C-terminal mechano growth factor protects dopamine neurons: A novel peptide that induces heme oxygenase-1

Experimental Neurology

Volumn 220, Issue 2, 2009, Pages 255-266

  Quesada, Arnulfo ^a,b   Micevych, Paul ^b   Handforth, Adrian ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

6 Hydroxydopamine; Dopamine; Heme oxygenase 1; Mechano growth factor; Neuroprotection; SH SY5Y

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; APOPTOSIS INDUCING FACTOR; DOPAMINE; HEME OXYGENASE 1; MECHANO GROWTH FACTOR; OXIDOPAMINE; PROTEIN KINASE B; PROTOPORPHYRIN ZINC; ROTENONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DRUG DOSE COMPARISON; ENZYME INDUCTION; ENZYME INHIBITION; FORELIMB; HUMAN; HUMAN CELL; MALE; MESENCEPHALON; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELL LINE; DNA FRAGMENTATION; DOPAMINE; ENZYME INDUCTION; HEME OXYGENASE-1; INSULIN-LIKE GROWTH FACTOR I; MEMBRANE POTENTIALS; MITOCHONDRIAL MEMBRANES; NEOSTRIATUM; NEURONS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUBSTANTIA NIGRA; SYMPATHOLYTICS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 71549163475     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.08.029     Document Type: Article

References (52)

1. Aleman A., Verhaar H.J., De Haan E.H., De Vries W.R., Samson M.M., Drent M.L., Van der Veen E.A., and Koppeschaar H.P. Insulin-like growth factor-I and cognitive function in healthy older men. J. Clin. Endocrinol. Metab. 84 (1999) 471-475
2. Alves da Costa C., Dunys J., Brau F., Wilk S., Cappai R., and Checler F. 6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation. J. Biol. Chem. 281 (2006) 9824-9831
3. Aperghis M., Johnson I.P., Cannon J., Yang S.Y., and Goldspink G. Different levels of neuroprotection by two insulin-like growth factor-I splice variants. Brain Res. 1009 (2004) 213-218
4. Armentero M.T., Fancellu R., Nappi G., Bramanti P., and Blandini F. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol. Dis. 22 (2006) 1-9
5. Blandini F., Armentero M.T., Fancellu R., Blaugrund E., and Nappi G. Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease. Exp. Neurol. 187 (2004) 455-459
6. Boujrad H., Gubkina O., Robert N., Krantic S., and Susin S.A. AIF-mediated programmed necrosis: a highly regulated way to die. Cell Cycle 6 (2007) 2612-2619
7. Busiguina S., Fernandez A.M., Barrios V., Clark R., Tolbert D.L., Berciano J., and Torres-Aleman I. Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol. Dis. 7 (2000) 657-665
8. Calabrese V., Lodi R., Tonon C., D'Agata V., Sapienza M., Scapagnini G., Mangiameli A., Pennisi G., Stella A.M., and Butterfield D.A. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J. Neurol. Sci. 233 (2005) 145-162
9. Carboni E., Tanda G.L., Frau R., and Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55 (1990) 1067-1070
10. Carpenter V., Matthews K., Devlin G., Stuart S., Jensen J., Conaglen J., Jeanplong F., Goldspink P., Yang S.Y., Goldspink G., Bass J., and McMahon C. Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction. Heart Lung Circ. 17 (2008) 33-39
11. Chen K., Gunter K., and Maines M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 75 (2000) 304-313
12. Cheng C.M., Mervis R.F., Niu S.L., Salem Jr. N., Witters L.A., Tseng V., Reinhardt R., and Bondy C.A. Insulin-like growth factor 1 is essential for normal dendritic growth. J. Neurosci. Res. 73 (2003) 1-9
13. Choi A.M., and Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am. J. Respir. Cell. Mol. Biol. 15 (1996) 9-19
14. Cregan S.P., Fortin A., MacLaurin J.G., Callaghan S.M., Cecconi F., Yu S.W., Dawson T.M., Dawson V.L., Park D.S., Kroemer G., and Slack R.S. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J. Cell. Biol. 158 (2002) 507-517
15. D'Ercole A.J., Ye P., Calikoglu A.S., and Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol. 13 (1996) 227-255
16. Dennery P.A., Sridhar K.J., Lee C.S., Wong H.E., Shokoohi V., Rodgers P.A., and Spitz D.R. Heme oxygenase-mediated resistance to oxygen toxicity in hamster fibroblasts. J. Biol. Chem. 272 (1997) 14937-14942
17. Deumens R., Blokland A., and Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 175 (2002) 303-317
18. Dluzniewska J., Sarnowska A., Beresewicz M., Johnson I., Srai S.K., Ramesh B., Goldspink G., Gorecki D.C., and Zablocka B. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia. FASEB J. 19 (2005) 1896-1898
19. Dore S., Takahashi M., Ferris C.D., Zakhary R., Hester L.D., Guastella D., and Snyder S.H. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2445-2450
20. Duchen M.R., Surin A., and Jacobson J. Imaging mitochondrial function in intact cells. Methods Enzymol. 361 (2003) 353-389
21. Fauconneau B., Petegnief V., Sanfeliu C., Piriou A., and Planas A.M. Induction of heat shock proteins (HSPs) by sodium arsenite in cultured astrocytes and reduction of hydrogen peroxide-induced cell death. J. Neurochem. 83 (2002) 1338-1348
22. Foresti R., and Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic. Res. 31 (1999) 459-475
23. Fukudome Y., Tabata T., Miyoshi T., Haruki S., Araishi K., Sawada S., and Kano M. Insulin-like growth factor-I as a promoting factor for cerebellar Purkinje cell development. Eur. J. Neurosci. 17 (2003) 2006-2016
24. Hsuan S.L., Klintworth H.M., and Xia Z. Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways. J. Neurosci. 26 (2006) 4481-4491
25. Huang E., Ong W.Y., Go M.L., and Garey L.J. Heme oxygenase-1 activity after excitotoxic injury: immunohistochemical localization of bilirubin in neurons and astrocytes and deleterious effects of heme oxygenase inhibition on neuronal survival after kainate treatment. J. Neurosci. Res. 80 (2005) 268-278
26. Hung S.Y., Liou H.C., Kang K.H., Wu R.M., Wen C.C., and Fu W.M. Overexpression of heme oxygenase-1 protects dopaminergic neurons against 1-methyl-4-phenylpyridinium-induced neurotoxicity. Mol. Pharmacol. 74 (2008) 1564-1575
27. McKoy G., Ashley W., Mander J., Yang S.Y., Williams N., Russell B., and Goldspink G. Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J. Physiol. 516 Pt. 2 (1999) 583-592
28. Motterlini R., Green C.J., and Foresti R. Regulation of heme oxygenase-1 by redox signals involving nitric oxide. Antioxid. Redox Signal 4 (2002) 615-624
29. Mura A., Mintz M., and Feldon J. Behavioral and anatomical effects of long-term l-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system. Exp. Neurol. 177 (2002) 252-264
30. Murahashi H., Azuma H., Zamzami N., Furuya K.J., Ikebuchi K., Yamaguchi M., Yamada Y., Sato N., Fujihara M., Kroemer G., and Ikeda H. Possible contribution of apoptosis-inducing factor (AIF) and reactive oxygen species (ROS) to UVB-induced caspase-independent cell death in the T cell line Jurkat. J. Leukoc. Biol. 73 (2003) 399-406
31. Nutt J.G., Burchiel K.J., Comella C.L., Jankovic J., Lang A.E., Laws Jr. E.R., Lozano A.M., Penn R.D., Simpson Jr. R.K., Stacy M., and Wooten G.F. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60 (2003) 69-73
32. Paul G., Meissner W., Rein S., Harnack D., Winter C., Hosmann K., Morgenstern R., and Kupsch A. Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp. Neurol. 185 (2004) 272-280
33. Paxinos G., Watson C., Pennisi M., and Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J. Neurosci. Methods 13 (1985) 139-143
34. Poss K.D., and Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10925-10930
35. Quesada A., Lee B.Y., and Micevych P.E. PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease. Dev. Neurobiol. (2008)
36. Quesada A., and Micevych P.E. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J. Neurosci. Res. 75 (2004) 107-116
37. Quesada A., Romeo H.E., and Micevych P. Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra. J. Comp. Neurol. 503 (2007) 198-208
38. Riddoch-Contreras J., Yang S.Y., Dick J.R., Goldspink G., Orrell R.W., and Greensmith L. Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1(G93A) mice. Exp. Neurol. (2008)
39. Sauer H., and Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59 (1994) 401-415
40. Scapagnini G., D'Agata V., Calabrese V., Pascale A., Colombrita C., Alkon D., and Cavallaro S. Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res. 954 (2002) 51-59
41. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., and Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39 (2000) 777-787
42. Schipper H.M., Cisse S., and Stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37 (1995) 758-768
43. Schipper H.M., Liberman A., and Stopa E.G. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease. Exp. Neurol. 150 (1998) 60-68
44. Shavlakadze T., Winn N., Rosenthal N., and Grounds M.D. Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm. IGF Res. 15 (2005) 4-18
45. Stoka V., Turk V., and Bredesen D.E. Differential regulation of the intrinsic pathway of apoptosis in brain and liver during ageing. FEBS Lett. 580 (2006) 3739-3745
46. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24 (1970) 485-493
47. Vicario-Abejon C., Yusta-Boyo M.J., Fernandez-Moreno C., and de Pablo F. Locally born olfactory bulb stem cells proliferate in response to insulin-related factors and require endogenous insulin-like growth factor-I for differentiation into neurons and glia. J. Neurosci. 23 (2003) 895-906
48. Winn N., Paul A., Musaro A., and Rosenthal N. Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease. Cold Spring Harb. Symp. Quant. Biol. 67 (2002) 507-518
49. Yang S., Alnaqeeb M., Simpson H., and Goldspink G. Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J. Muscle Res. Cell. Motil. 17 (1996) 487-495
50. Yang S.Y., and Goldspink G. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett. 522 (2002) 156-160
51. Yang Y., Ohta K., Shimizu M., Morimoto K., Goto C., Nakai A., Toma T., Kasahara Y., Yachie A., Seki H., and Koizumi S. Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury. Kidney Int. 64 (2003) 1302-1309
52. Zuch C.L., Nordstroem V.K., Briedrick L.A., Hoernig G.R., Granholm A.C., and Bickford P.C. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J. Comp. Neurol. 427 (2000) 440-454